COVID Vaccine (Moderna) Available Here
Updated: Dec 3, 2021
We have received another shipment of the Moderna COVID Vaccine and are offering Walk-In availability on Wednesday - Friday 10:00am - 5:00pm. If you have a group larger than 5, please call ahead to schedule an appointment. This will help make your experience more efficient and we can plan ahead for your group.
When you walk in for your vaccine, you will be asked to complete a pre-screening questionnaire and we will also ask for your prescription insurance information or Medicare Part B card. If you do not have either, you are still able to receive vaccine free of charge if you are eligible for vaccine.
People who are eligible for vaccine:
*Anyone 18+ who has not had any doses of COVID vaccine
*People 18+ who have received 1 dose of Moderna COVID vaccine and it has been 28 days or more since your first dose
* People 18+ who have received 2 doses of Moderna COVID vaccine and meet the following criteria for a booster dose. If you are immunocompromised, we suggest you talk to your physician about whether they recommend a COVID booster dose for you.
From CDC.gov "Effective August 13, 2021, CDC recommends that people who are moderately to severely immunocompromised receive an additional dose of an mRNA COVID-19 Vaccine (Pfizer-BioNTech or Moderna) at least 28 days after the completion of the initial mRNA COVID-19 vaccine series. Available data show that these people don’t always build adequate levels of protection after an initial 2-dose primary mRNA COVID-19 vaccine series. The data also show that they may benefit from receiving an additional dose of an mRNA vaccine to develop as much protection as possible against COVID-19.
Currently, CDC is recommending that moderately to severely immunocompromised people receive an additional dose. This includes people who have:
Active treatment for solid tumor and hematologic malignancies
Receipt of solid-organ transplant and taking immunosuppressive therapy
Receipt of CAR-T-cell or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
Moderate or severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome)
Advanced or untreated HIV infection
Active treatment with high-dose corticosteroids (i.e., ≥20mg prednisone or equivalent per day), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, tumor-necrosis (TNF) blockers, and other biologic agents that are immunosuppressive or immunomodulatory."